Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142339 |
| CAS No | NA |
| Mol.F. | C13H8N2O2 |
| Mol.Wt. | 224.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142340 |
| CAS No | NA |
| Mol.F. | C21H18N4O6S2 |
| Mol.Wt. | 486.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142341 |
| CAS No | NA |
| Mol.F. | C12H17N3O5S |
| Mol.Wt. | 315.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142342 |
| CAS No | NA |
| Mol.F. | C7H9N3O4S |
| Mol.Wt. | 231.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142343 |
| CAS No | NA |
| Mol.F. | C24H23N3O6 |
| Mol.Wt. | 449.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142344 |
| CAS No | NA |
| Mol.F. | C17H17N3O5 |
| Mol.Wt. | 343.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142345 |
| CAS No | NA |
| Mol.F. | C18H19N3O5 |
| Mol.Wt. | 357.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142346 |
| CAS No | NA |
| Mol.F. | C12H12Cl2N4O3 |
| Mol.Wt. | 331.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142347 |
| CAS No | NA |
| Mol.F. | C11H10Cl2N4O3 |
| Mol.Wt. | 317.13 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142348 |
| CAS No | NA |
| Mol.F. | C10H5Cl3N4O2 |
| Mol.Wt. | 319.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142349 |
| CAS No | NA |
| Mol.F. | C10H6Cl2N4O3 |
| Mol.Wt. | 301.08 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142350 |
| CAS No | NA |
| Mol.F. | C11H10Cl3N3O5 |
| Mol.Wt. | 370.57 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142351 |
| CAS No | NA |
| Mol.F. | C8H6Cl2N4O |
| Mol.Wt. | 245.06 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142352 |
| CAS No | NA |
| Mol.F. | C11H14ClN3O3 |
| Mol.Wt. | 271.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142353 |
| CAS No | NA |
| Mol.F. | C21H19N3O8 |
| Mol.Wt. | 441.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142354 |
| CAS No | NA |
| Mol.F. | C58H72N8O18 |
| Mol.Wt. | 1169.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |